Literature DB >> 21256928

Anxiety-like behavior and proinflammatory cytokine levels in the brain of C57BL/6 mice infected with Plasmodium berghei (strain ANKA).

Aline Silva de Miranda1, Norinne Lacerda-Queiroz, Márcia de Carvalho Vilela, David Henrique Rodrigues, Milene Alvarenga Rachid, João Quevedo, Antônio Lúcio Teixeira.   

Abstract

Cerebral malaria (CM) is a severe complication resulting from Plasmodium falciparum infection. The underlying mechanisms of CM pathogenesis remain incompletely understood. The imbalance between the release of proinflammatory and anti-inflammatory cytokines has been associated with central nervous system dysfunction found in human and experimental CM. The current study investigated anxiety-like behavior, histopathological changes and release of brain cytokines in C57BL/6 mice infected with Plasmodium berghei strain ANKA (PbA). Anxiety-like behavior was assessed in control and PbA-infected mice using the elevated plus maze test. Histopathological changes in brain tissue were assessed by haematoxylin and eosin staining. Brain concentration of the cytokines IL-1β, IL-4, IL-10, TNF-α and IFN-γ was determined by ELISA. We found that PbA-infected mice on day 5 post-infection presented anxiety symptoms, histopathological alterations in the brainstem, cerebrum and hippocampus and increased cerebral levels of proinflammatory cytokines IL-1β and TNF-α. These findings suggest an involvement of central nervous system inflammatory mediators in anxiety symptoms found in CM.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256928     DOI: 10.1016/j.neulet.2011.01.038

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity.

Authors:  Chaya D Patel; Iara M Backes; Sean A Taylor; Yike Jiang; Arnaud Marchant; Jean M Pesola; Donald M Coen; David M Knipe; Margaret E Ackerman; David A Leib
Journal:  Sci Transl Med       Date:  2019-04-10       Impact factor: 17.956

2.  Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.

Authors:  W Armand Guiguemde; Nicholas H Hunt; Jintao Guo; Annael Marciano; Richard K Haynes; Julie Clark; R Kiplin Guy; Jacob Golenser
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

3.  Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based β-methasone nanodrug.

Authors:  Jintao Guo; Judith H Waknine-Grinberg; Andrew J Mitchell; Yechezkel Barenholz; Jacob Golenser
Journal:  Biomed Res Int       Date:  2014-07-14       Impact factor: 3.411

4.  Pathogenesis of Plasmodium berghei ANKA infection in the gerbil (Meriones unguiculatus) as an experimental model for severe malaria.

Authors:  Quazim Olawale Junaid; Loke Tim Khaw; Rohela Mahmud; Kien Chai Ong; Yee Ling Lau; Prajakta Uttam Borade; Jonathan Wee Kent Liew; Sinnadurai Sivanandam; Kum Thong Wong; Indra Vythilingam
Journal:  Parasite       Date:  2017-10-16       Impact factor: 3.000

Review 5.  Pathophysiology and neurologic sequelae of cerebral malaria.

Authors:  Nicoline Schiess; Andres Villabona-Rueda; Karissa E Cottier; Katherine Huether; James Chipeta; Monique F Stins
Journal:  Malar J       Date:  2020-07-23       Impact factor: 2.979

6.  Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain.

Authors:  Nathaniel Shryock; Cortez McBerry; Rosa Maria Salazar Gonzalez; Steven Janes; Fabio T M Costa; Julio Aliberti
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

7.  Effect of mushroom Agaricus blazei on immune response and development of experimental cerebral malaria.

Authors:  Cynthia H Val; Fátima Brant; Aline S Miranda; Flávia G Rodrigues; Bruno C L Oliveira; Elândia A Santos; Diego R R Assis; Lísia Esper; Bruno C Silva; Milene A Rachid; Herbert B Tanowitz; Antônio L Teixeira; Mauro M Teixeira; Wiliam C B Régis; Fabiana S Machado
Journal:  Malar J       Date:  2015-08-11       Impact factor: 2.979

8.  Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria.

Authors:  Aline S Miranda; Fátima Brant; Natália P Rocha; Daniel Cisalpino; David H Rodrigues; Danielle G Souza; Fabiana S Machado; Milene A Rachid; Antônio L Teixeira; Alline C Campos
Journal:  Malar J       Date:  2013-11-02       Impact factor: 2.979

9.  Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?

Authors:  Manuela Polimeni; Mauro Prato
Journal:  Fluids Barriers CNS       Date:  2014-01-27

10.  Mesenchymal stromal cells protect against vascular damage and depression-like behavior in mice surviving cerebral malaria.

Authors:  Maiara N Lima; Helena A Oliveira; Paula M Fagundes; Vanessa Estato; Adriano Y O Silva; Rodrigo J R X Freitas; Beatriz A B R Passos; Karina S Oliveira; Camila N Batista; Adriana L Vallochi; Patricia R M Rocco; Hugo C Castro-Faria-Neto; Tatiana Maron-Gutierrez
Journal:  Stem Cell Res Ther       Date:  2020-08-26       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.